English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Open

Presents the pdf analysis as premium feature

PDF Analysis

Insights

Presents the summarisation as premium feature

Summarisation

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

A young male of hemorrhagic cerebral infarction associated with finasteride and minoxidil Tomoyuki Kuno, M.D., Yuto Uchida, M.D., Toshihiko Usami, M.D., Susumu Kobayashi, M.D., Koji Takada, M.D., Ph.D., Masahiro Oomura, M.D., Ph.D., and Noriyuki Matsukawa, M.D., Ph.D. Department of Neurology, Toyokawa City Hospital Department of Neurology, Nagoya City University Graduate School of Medical Sciences Department of Radiology, Toyokawa City Hospital We report a young male of hemorrhagic cerebral infarction associated with finasteride and minoxidil. He had undertaken 0.4 mg of finasteride and 4 mg of minoxidil daily for 8 months. During his exercising, he suddenly presented with a headache, followed by visual disorder. On admission, his brain MRI showed hemorrhagic cerebral infarction in the right occipital lobe. However, our examinations that revealed the cause of his cerebral infarction showed no abnormalities. Thereafter, we suspected adverse effects of finasteride and minoxidil and discontinued these medications. He never had recurrent stroke since then. We emphasize the importance of a detailed interview including unusual medications to investigate the cause of cerebral infarction.